“Lebrikizumab Improved Skin Signs, Quality of Life, and Showed High Levels of Patient Satisfaction in Adult and Adolescent Patients with Moderate-to-Severe Atopic Dermatitis and Skin of Color” (2025) SKIN The Journal of Cutaneous Medicine, 9(2), p. s549. doi:10.25251/skin.10.supp.549.